• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Metronomic cyclophosphamide in elderly patients with advanced, castration-resistant prostate cancer.

作者信息

Fontana Andrea, Bocci Guido, Galli Luca, D'Arcangelo Manolo, Derosa Lisa, Fioravanti Anna, Orlandi Paola, Barletta Maria Teresa, Landi Lorenza, Bursi Simona, Minuti Gabriele, Bona Eleonora, Grazzini Ilaria, Danesi Romano, Falcone Alfredo

出版信息

J Am Geriatr Soc. 2010 May;58(5):986-8. doi: 10.1111/j.1532-5415.2010.02833.x.

DOI:10.1111/j.1532-5415.2010.02833.x
PMID:20722827
Abstract
摘要

相似文献

1
Metronomic cyclophosphamide in elderly patients with advanced, castration-resistant prostate cancer.老年晚期去势抵抗性前列腺癌患者的节拍性环磷酰胺治疗
J Am Geriatr Soc. 2010 May;58(5):986-8. doi: 10.1111/j.1532-5415.2010.02833.x.
2
Clinical and pharmacodynamic evaluation of metronomic cyclophosphamide, celecoxib, and dexamethasone in advanced hormone-refractory prostate cancer.节拍性环磷酰胺、塞来昔布和地塞米松用于晚期激素难治性前列腺癌的临床及药效学评价
Clin Cancer Res. 2009 Aug 1;15(15):4954-62. doi: 10.1158/1078-0432.CCR-08-3317. Epub 2009 Jul 21.
3
Retrospective analysis of an oral combination of dexamethasone, uracil plus tegafur and cyclophosphamide for hormone-refractory prostate cancer.地塞米松、尿嘧啶加替加氟和环磷酰胺口服联合治疗激素难治性前列腺癌的回顾性分析。
Jpn J Clin Oncol. 2011 Feb;41(2):253-9. doi: 10.1093/jjco/hyq178. Epub 2010 Nov 10.
4
Oral estramustine and cyclophosphamide in patients with metastatic hormone refractory prostate carcinoma: a phase II study.口服雌莫司汀与环磷酰胺治疗转移性激素难治性前列腺癌患者：一项II期研究。
Cancer. 2000 Mar 15;88(6):1438-44.
5
Oral/metronomic cyclophosphamide-based chemotherapy as option for patients with castration-refractory prostate cancer: review of the literature.口服/节拍式环磷酰胺为基础的化疗作为去势抵抗性前列腺癌患者的选择：文献综述。
Cancer Treat Rev. 2011 Oct;37(6):444-55. doi: 10.1016/j.ctrv.2010.12.006. Epub 2011 Jan 28.
6
Metronomic chemotherapy-induced bilateral subdural hematoma in a child with meningeal carcinomatosis.节拍化疗诱发一名患脑膜癌病儿童双侧硬膜下血肿。
Pediatr Blood Cancer. 2009 Aug;53(2):246-7. doi: 10.1002/pbc.22022.
7
Low dose metronomic oral cyclophosphamide for hormone resistant prostate cancer: a phase II study.低剂量节拍口服环磷酰胺治疗激素抵抗性前列腺癌：一项II期研究。
J Urol. 2007 Jun;177(6):2136-40; discussion 2140. doi: 10.1016/j.juro.2007.01.143.
8
Metronomic therapy with cyclophosphamide and dexamethasone for prostate carcinoma.环磷酰胺与地塞米松节律性化疗治疗前列腺癌
Cancer. 2003 Oct 15;98(8):1643-8. doi: 10.1002/cncr.11713.
9
Long-term disease stabilization in a patient with castration-resistant metastatic prostate cancer by the addition of lenalidomide to low-dose dexamethasone and celecoxib.在一名去势抵抗性转移性前列腺癌患者中，通过在低剂量地塞米松和塞来昔布基础上加用来那度胺实现长期疾病稳定。
Onkologie. 2012;35(5):279-82. doi: 10.1159/000337403. Epub 2012 Apr 24.
10
Paraneoplastic pemphigus treated with dexamethasone/ cyclophosphamide pulse therapy.
Eur J Dermatol. 1998 Dec;8(8):551-3.

引用本文的文献

1
A phase 1 trial of human telomerase reverse transcriptase (hTERT) vaccination combined with therapeutic strategies to control immune-suppressor mechanisms.一项关于人端粒酶逆转录酶（hTERT）疫苗接种联合控制免疫抑制机制治疗策略的1期试验。
Exp Biol Med (Maywood). 2024 Jan 31;249:10021. doi: 10.3389/ebm.2024.10021. eCollection 2024.
2
Metronomic Chemotherapy in Elderly Patients.老年患者的节拍化疗。
Curr Oncol Rep. 2024 Apr;26(4):359-376. doi: 10.1007/s11912-024-01505-w. Epub 2024 Mar 7.
3
Activity and safety of KEES - an oral multi-drug chemo-hormonal metronomic combination regimen in metastatic castration-resistant prostate cancer.
KEES（一种口服多药物化疗-激素节拍组合方案）在转移性去势抵抗性前列腺癌中的活性和安全性。
BMC Cancer. 2023 Apr 4;23(1):309. doi: 10.1186/s12885-023-10780-y.
4
Metronomic Chemotherapy for Advanced Prostate Cancer: A Literature Review.晚期前列腺癌的节拍化疗：文献综述
J Clin Med. 2022 May 15;11(10):2783. doi: 10.3390/jcm11102783.
5
Metronomic Chemotherapy: A Systematic Review of the Literature and Clinical Experience.节拍化疗：文献与临床经验的系统评价
J Oncol. 2019 Mar 20;2019:5483791. doi: 10.1155/2019/5483791. eCollection 2019.
6
Clinical, pharmacodynamic and pharmacokinetic results of a prospective phase II study on oral metronomic vinorelbine and dexamethasone in castration-resistant prostate cancer patients.一项关于口服节拍性长春瑞滨和地塞米松治疗去势抵抗性前列腺癌患者的前瞻性II期研究的临床、药效学和药代动力学结果
Invest New Drugs. 2016 Dec;34(6):760-770. doi: 10.1007/s10637-016-0385-0. Epub 2016 Aug 24.
7
Angiogenesis inhibitors in cancer therapy: mechanistic perspective on classification and treatment rationales.癌症治疗中的血管生成抑制剂：分类及治疗原理的机制视角
Br J Pharmacol. 2013 Oct;170(4):712-29. doi: 10.1111/bph.12344.
8
VEGF-A polymorphisms predict progression-free survival among advanced castration-resistant prostate cancer patients treated with metronomic cyclophosphamide.血管内皮生长因子 A 多态性可预测接受环磷酰胺节拍化疗的晚期去势抵抗性前列腺癌患者的无进展生存期。
Br J Cancer. 2013 Aug 20;109(4):957-64. doi: 10.1038/bjc.2013.398. Epub 2013 Jul 16.
9
Preclinical analysis of resistance and cross-resistance to low-dose metronomic chemotherapy.低剂量节拍化疗耐药性和交叉耐药性的临床前分析。
Invest New Drugs. 2014 Feb;32(1):47-59. doi: 10.1007/s10637-013-9974-3. Epub 2013 Jun 2.
10
Clinical opportunities and challenges in targeting tumour dormancy.靶向肿瘤休眠的临床机遇与挑战
Nat Rev Clin Oncol. 2013 Jan;10(1):41-51. doi: 10.1038/nrclinonc.2012.207. Epub 2012 Nov 27.